AU2005285246B2 - Isolated lineage negative hematopoietic stem cells and methods of treatment therewith - Google Patents
Isolated lineage negative hematopoietic stem cells and methods of treatment therewith Download PDFInfo
- Publication number
- AU2005285246B2 AU2005285246B2 AU2005285246A AU2005285246A AU2005285246B2 AU 2005285246 B2 AU2005285246 B2 AU 2005285246B2 AU 2005285246 A AU2005285246 A AU 2005285246A AU 2005285246 A AU2005285246 A AU 2005285246A AU 2005285246 B2 AU2005285246 B2 AU 2005285246B2
- Authority
- AU
- Australia
- Prior art keywords
- cells
- lin
- hematopoietic stem
- hsc
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
- C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/933,634 | 2004-09-03 | ||
US10/933,634 US20050129665A1 (en) | 2002-07-25 | 2004-09-03 | Isolated lineage negative hematopoietic stem cells and methods of treatment therewith |
PCT/US2005/031304 WO2006031467A2 (en) | 2002-07-25 | 2005-09-02 | Isolated lineage negative hematopoietic stem cells and methods of treatment therewith |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2005285246A1 AU2005285246A1 (en) | 2006-03-23 |
AU2005285246B2 true AU2005285246B2 (en) | 2011-07-21 |
Family
ID=37903853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2005285246A Ceased AU2005285246B2 (en) | 2004-09-03 | 2005-09-02 | Isolated lineage negative hematopoietic stem cells and methods of treatment therewith |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1802199A4 (zh) |
JP (1) | JP2008512376A (zh) |
KR (1) | KR101309500B1 (zh) |
CN (1) | CN101052305B (zh) |
AU (1) | AU2005285246B2 (zh) |
CA (1) | CA2579292A1 (zh) |
MX (1) | MX2007002639A (zh) |
ZA (1) | ZA200702607B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2554662A1 (en) * | 2011-08-05 | 2013-02-06 | M Maria Pia Cosma | Methods of treatment of retinal degeneration diseases |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004010959A2 (en) * | 2002-07-25 | 2004-02-05 | The Scripps Research Institute | Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5928638A (en) * | 1996-06-17 | 1999-07-27 | Systemix, Inc. | Methods for gene transfer |
US7219016B2 (en) * | 2001-04-20 | 2007-05-15 | Yale University | Systems and methods for automated analysis of cells and tissues |
US6939378B2 (en) * | 2001-06-01 | 2005-09-06 | The Board Of Trustees Of The Leland Stanford Junior University | Microfabricated tissue as a substrate for pigment epithelium transplantation |
ATE378056T1 (de) * | 2001-08-10 | 2007-11-15 | Imclone Systems Inc | Medizinische verwendung von stammzellen, die vegfr-1 exprimieren |
WO2003038077A1 (fr) * | 2001-10-30 | 2003-05-08 | Daiichi Pharmaceutical Co., Ltd. | Procede d'amplification des cellules hematopoietiques souches |
CN1194086C (zh) * | 2002-02-01 | 2005-03-23 | 北京科宇联合干细胞生物技术有限公司 | 一种神经干细胞制剂的制备方法 |
-
2005
- 2005-09-02 EP EP05814042A patent/EP1802199A4/en not_active Withdrawn
- 2005-09-02 CN CN2005800379820A patent/CN101052305B/zh not_active Expired - Fee Related
- 2005-09-02 KR KR1020077007667A patent/KR101309500B1/ko not_active IP Right Cessation
- 2005-09-02 CA CA002579292A patent/CA2579292A1/en not_active Abandoned
- 2005-09-02 MX MX2007002639A patent/MX2007002639A/es active IP Right Grant
- 2005-09-02 JP JP2007530394A patent/JP2008512376A/ja active Pending
- 2005-09-02 AU AU2005285246A patent/AU2005285246B2/en not_active Ceased
-
2007
- 2007-03-28 ZA ZA200702607A patent/ZA200702607B/xx unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004010959A2 (en) * | 2002-07-25 | 2004-02-05 | The Scripps Research Institute | Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
WO2004098499A2 (en) * | 2002-07-25 | 2004-11-18 | The Scripps Research Institute | Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
Non-Patent Citations (1)
Title |
---|
Otani, A. et al. 2002 Nature Medicine, vol. 8, p. 1004-1010 * |
Also Published As
Publication number | Publication date |
---|---|
ZA200702607B (en) | 2008-08-27 |
KR101309500B1 (ko) | 2013-09-24 |
CA2579292A1 (en) | 2006-03-23 |
AU2005285246A1 (en) | 2006-03-23 |
MX2007002639A (es) | 2007-08-06 |
EP1802199A4 (en) | 2008-08-27 |
EP1802199A2 (en) | 2007-07-04 |
CN101052305B (zh) | 2012-10-10 |
KR20070104512A (ko) | 2007-10-26 |
JP2008512376A (ja) | 2008-04-24 |
CN101052305A (zh) | 2007-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7838290B2 (en) | Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith | |
EP1935976B1 (en) | Transfected myeloid-like cells for the treatment of retinopathy of prematurity and related diseases | |
WO2004098499A2 (en) | Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith | |
AU2007322084B2 (en) | Isolated myeloid-like cell populations and methods of treatment therewith | |
US8900567B2 (en) | Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells | |
US20110201108A1 (en) | Isolated myeloid-like bone marrow cell populations and methods of treatment therewith | |
US20100303768A1 (en) | Isolated lineage negative hematopoietic stem cells and methods of treatment therewith | |
AU2005239702B2 (en) | Hematopoietic stem cells and methods of treatment of neovascular diseases therewith | |
WO2006031467A9 (en) | Isolated lineage negative hematopoietic stem cells and methods of treatment therewith | |
US20060104962A1 (en) | Transfected hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith | |
AU2005285246B2 (en) | Isolated lineage negative hematopoietic stem cells and methods of treatment therewith |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) | ||
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |